Healius Limited (HLS.AX)
AUD 1.4
(-1.75%)
AUD 1.4
(-1.75%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 1.74 Billion AUD | 2.3% |
| 2023 | 1.7 Billion AUD | -25.43% |
| 2022 | 2.28 Billion AUD | 20.42% |
| 2021 | 1.9 Billion AUD | 22.07% |
| 2020 | 1.55 Billion AUD | -0.6% |
| 2019 | 1.56 Billion AUD | -8.11% |
| 2018 | 1.7 Billion AUD | 2.77% |
| 2017 | 1.65 Billion AUD | 1.02% |
| 2016 | 1.64 Billion AUD | 3.94% |
| 2015 | 1.57 Billion AUD | 3.65% |
| 2014 | 1.52 Billion AUD | 5.84% |
| 2013 | 1.44 Billion AUD | 3.53% |
| 2012 | 1.39 Billion AUD | 6.26% |
| 2011 | 1.3 Billion AUD | 1.72% |
| 2010 | 1.28 Billion AUD | -3.14% |
| 2009 | 1.32 Billion AUD | 104.51% |
| 2008 | 649.64 Million AUD | 137.75% |
| 2007 | 273.24 Million AUD | 13.51% |
| 2006 | 240.71 Million AUD | 26.26% |
| 2005 | 190.64 Million AUD | 26.74% |
| 2004 | 150.42 Million AUD | 18.62% |
| 2003 | 126.81 Million AUD | 23.21% |
| 2002 | 102.93 Million AUD | 14.67% |
| 2001 | 89.76 Million AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| 1998 | - AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 849 Million AUD | 0.0% |
| 2024 Q4 | 897.2 Million AUD | 0.0% |
| 2024 FY | 1.74 Billion AUD | 2.3% |
| 2023 FY | 1.7 Billion AUD | -25.43% |
| 2023 Q2 | 864.1 Million AUD | 0.0% |
| 2023 Q4 | 842.8 Million AUD | 0.0% |
| 2022 FY | 2.28 Billion AUD | 20.42% |
| 2022 Q4 | 998.2 Million AUD | 0.0% |
| 2022 Q2 | 1.33 Billion AUD | 0.0% |
| 2021 Q2 | 943.8 Million AUD | 0.0% |
| 2021 Q4 | 956.9 Million AUD | 0.0% |
| 2021 FY | 1.9 Billion AUD | 22.07% |
| 2020 FY | 1.55 Billion AUD | -0.6% |
| 2020 Q2 | 945.1 Million AUD | 0.0% |
| 2020 Q4 | 639.5 Million AUD | 0.0% |
| 2019 Q2 | 879.9 Million AUD | 0.0% |
| 2019 Q4 | 932.9 Million AUD | 0.0% |
| 2019 FY | 1.56 Billion AUD | -8.11% |
| 2018 Q2 | 832.7 Million AUD | 0.0% |
| 2018 Q4 | 871.9 Million AUD | 0.0% |
| 2018 FY | 1.7 Billion AUD | 2.77% |
| 2017 Q2 | 808.7 Million AUD | 0.0% |
| 2017 FY | 1.65 Billion AUD | 1.02% |
| 2017 Q4 | 849.9 Million AUD | 0.0% |
| 2016 Q2 | 814.1 Million AUD | 0.0% |
| 2016 Q4 | 827.8 Million AUD | 0.0% |
| 2016 FY | 1.64 Billion AUD | 3.94% |
| 2015 Q2 | 798.58 Million AUD | 0.0% |
| 2015 FY | 1.57 Billion AUD | 3.65% |
| 2015 Q4 | - AUD | 0.0% |
| 2014 FY | 1.52 Billion AUD | 5.84% |
| 2014 Q4 | 773.29 Million AUD | 0.0% |
| 2014 Q2 | 750.82 Million AUD | 0.0% |
| 2013 Q4 | 727.5 Million AUD | 0.0% |
| 2013 Q2 | 712.53 Million AUD | 0.0% |
| 2013 FY | 1.44 Billion AUD | 3.53% |
| 2012 Q2 | 347.72 Million AUD | 6.26% |
| 2012 FY | 1.39 Billion AUD | 6.26% |
| 2012 Q4 | - AUD | -100.0% |
| 2012 Q3 | 347.72 Million AUD | 0.0% |
| 2012 Q1 | 327.24 Million AUD | 0.0% |
| 2011 Q4 | - AUD | -100.0% |
| 2011 Q3 | 327.24 Million AUD | 0.0% |
| 2011 Q1 | 321.7 Million AUD | 0.0% |
| 2011 FY | 1.3 Billion AUD | 1.72% |
| 2011 Q2 | 327.24 Million AUD | 1.72% |
| 2010 Q1 | 331.99 Million AUD | 0.0% |
| 2010 FY | 1.28 Billion AUD | -3.14% |
| 2010 Q4 | - AUD | -100.0% |
| 2010 Q3 | 321.7 Million AUD | 0.0% |
| 2010 Q2 | 321.7 Million AUD | -3.1% |
| 2009 Q3 | 331.99 Million AUD | 0.0% |
| 2009 Q4 | - AUD | -100.0% |
| 2009 FY | 1.32 Billion AUD | 104.51% |
| 2009 Q1 | 162.33 Million AUD | 0.0% |
| 2009 Q2 | 331.99 Million AUD | 104.52% |
| 2008 FY | 649.64 Million AUD | 137.75% |
| 2008 Q3 | 162.33 Million AUD | 0.0% |
| 2008 Q4 | - AUD | -100.0% |
| 2008 Q2 | 162.33 Million AUD | 139.44% |
| 2008 Q1 | 67.79 Million AUD | 0.0% |
| 2007 FY | 273.24 Million AUD | 13.51% |
| 2007 Q4 | - AUD | -100.0% |
| 2007 Q3 | 67.79 Million AUD | 0.0% |
| 2007 Q2 | 67.79 Million AUD | 12.66% |
| 2007 Q1 | 60.17 Million AUD | 0.0% |
| 2006 Q4 | - AUD | -100.0% |
| 2006 Q1 | 49.49 Million AUD | 0.0% |
| 2006 Q2 | 60.17 Million AUD | 21.57% |
| 2006 Q3 | 60.17 Million AUD | 0.0% |
| 2006 FY | 240.71 Million AUD | 26.26% |
| 2005 Q1 | 37.6 Million AUD | 0.0% |
| 2005 FY | 190.64 Million AUD | 26.74% |
| 2005 Q3 | 49.49 Million AUD | 0.0% |
| 2005 Q2 | 49.49 Million AUD | 31.63% |
| 2005 Q4 | - AUD | -100.0% |
| 2004 FY | 150.42 Million AUD | 18.62% |
| 2004 Q2 | 37.6 Million AUD | 18.62% |
| 2004 Q4 | - AUD | -100.0% |
| 2004 Q1 | 31.7 Million AUD | 0.0% |
| 2004 Q3 | 37.6 Million AUD | 0.0% |
| 2003 Q4 | - AUD | -100.0% |
| 2003 Q3 | 31.7 Million AUD | 0.0% |
| 2003 Q2 | 31.7 Million AUD | 23.21% |
| 2003 FY | 126.81 Million AUD | 23.21% |
| 2003 Q1 | 25.73 Million AUD | 0.0% |
| 2002 Q4 | - AUD | -100.0% |
| 2002 Q2 | 25.73 Million AUD | 14.67% |
| 2002 FY | 102.93 Million AUD | 14.67% |
| 2002 Q1 | 22.44 Million AUD | 0.0% |
| 2002 Q3 | 25.73 Million AUD | 0.0% |
| 2001 Q1 | - AUD | 0.0% |
| 2001 Q3 | 22.44 Million AUD | 0.0% |
| 2001 FY | 89.76 Million AUD | 0.0% |
| 2001 Q2 | 22.44 Million AUD | 0.0% |
| 2001 Q4 | - AUD | -100.0% |
| 2000 Q4 | - AUD | 0.0% |
| 2000 Q1 | - AUD | 0.0% |
| 2000 Q3 | - AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| 2000 Q2 | - AUD | 0.0% |
| 1999 Q4 | - AUD | 0.0% |
| 1999 Q1 | - AUD | 0.0% |
| 1999 Q3 | - AUD | 0.0% |
| 1999 Q2 | - AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| 1998 FY | - AUD | 0.0% |
| 1998 Q3 | - AUD | 0.0% |
| 1998 Q4 | - AUD | 0.0% |
| 1998 Q2 | - AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Australian Clinical Labs Limited | 689.72 Million AUD | -153.172% |
| BCAL Diagnostics Limited | 3.09 Million AUD | -56263.596% |
| Genetic Signatures Limited | 9.76 Million AUD | -17780.401% |
| Genetic Technologies Limited | 7.66 Million AUD | -22682.116% |
| Imagion Biosystems Limited | 1.36 Million AUD | -127595.018% |
| Integral Diagnostics Limited | 469.69 Million AUD | -271.772% |
| INOVIQ Ltd | 535.11 Thousand AUD | -326220.55% |
| Microba Life Sciences Limited | 12.09 Million AUD | -14343.276% |
| Monash IVF Group Limited | 254.96 Million AUD | -584.892% |
| Rhythm Biosciences Limited | 1.69 Million AUD | -103216.64% |
| Sonic Healthcare Limited | 8.93 Billion AUD | 80.455% |